Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-25 @ 4:25 AM
NCT ID:
NCT01252420
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18 years or older with acute symptomatic provoked or unprovoked distal vein thrombosis (axial or muscular veins but not involving trifurcation or distal popliteal vein)
* Absence of symptomatic pulmonary embolism
Exclusion Criteria:
* DVT involving trifurcation or more proximal leg veins on imaging
* Prior DVT
* Active malignancy ie present at time of diagnosis, or on treatment, or treatment completed within 3 months
* Ongoing risk factors for propagation e.g. immobility (\>50% of day in bed or ≥72 hours), plaster cast or non-weight bearing
* Other indication for therapeutic anticoagulation (e.g. AF)
* Active gastro-oesophageal ulceration or bleeding
* Other high risk for bleeding (e.g. recent neurosurgery, vascular retinopathy, coagulopathy)
* Platelet count \<80 x 109/L
* Renal impairment (CrCl \<30ml/min) • Pregnancy or lactation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01252420
Study Brief:
Protocol Section:
NCT01252420